Romosozumab in postmenopausal women with low bone mineral density. [electronic resource]
Producer: 20140211Description: 412-20 p. digitalISSN:- 1533-4406
- Aged
- Aged, 80 and over
- Alendronate -- pharmacology
- Antibodies, Monoclonal -- administration & dosage
- Biomarkers -- metabolism
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Bone Remodeling -- drug effects
- Calcium -- blood
- Drug Administration Schedule
- Female
- Humans
- Injections, Subcutaneous
- Least-Squares Analysis
- Lumbar Vertebrae -- drug effects
- Middle Aged
- Osteoporosis, Postmenopausal -- drug therapy
- Teriparatide -- pharmacology
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.